局部注射放射性核素治疗实体瘤的探讨

张旭光

局部注射放射性核素治疗实体瘤的探讨

张旭光

文章导航 > 国际放射医学核医学杂志 > 2002, 26 > 3: (105-108118)

引用本文:

Citation:

局部注射放射性核素治疗实体瘤的探讨

张旭光

215007 苏州, 苏州大学核医学院

作者简介: 张旭光(1964-),男,徐州医学院肿瘤防治研究所副主任医师,副教授,博士研究生,主要从事肿瘤的放射治疗研究。;

基金项目:
江苏省科技厅社会发展基金资助项目(BS2001051)
中图分类号: R817.5

Probe into intratumoral injection of radionuclide treating solid tumor

ZHANG Xu-guang

Institution of Oncology for Prevention and Treatment, Xuzhou Medical College, Jiangsu Xuzhou 221006, China
CLC number: R817.5

摘要: 局部注射放射性核素治疗实体瘤是新型的内放疗手段,己得到广泛重视。它能够可靠地选择性局部杀伤肿瘤,减少对机体的损伤。但是,其载体选择、辐射剂量监测、实用治疗方案确定等方面,均有待深化研究。
- 多巴胺 /
- D₃受体 /
- 配体 /
- 四氢氨基萘满
Abstract: DIntratumoral injection of radionuclide is a new method of internal radiotherapy that has been stressed in the fields of basic research and clinical practice. It can selectively kill regional tumor while decrease radiation injury of hu-man body. But in the sides of how to select a suitable carrier, to monitor radiation dose and to determine treatment plan, we have not established a dependable system.
- intratumoral injection /
- internal radiotherapy /
- carrier /
- dose monitor
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Tian JH,Xu BX,Zhang JM. Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies[J].Journal of Nuclear Medicine,1996,(06):958-963.
[2]	Wang Shyh-Jen,Lin Wan-Yu,Chen Min-nan. Intratumoral injection of rhenium-188 microspheres into an animal of hepatoma[J].Journal of Nuclear Medicine,1998,(10):1752-1757.
[3]	Roberson PL,Ten Haken RK,McShan DL. Three-dimensional tumor dosimetry for hepatic yttrium-90-microsphere therapy[J].Journal of Nuclear Medicine,1992,(05):735-738.
[4]	Siegel JA,Pawlyk DA,Lee RE. Tumor red marrow and organ dosimetry for-(131)I-labelled anti-cayconomaembryomic antigen monocloned antibody[J].Cancer Research,1990,(50):1039-1042.
[5]	Gray BN,Burtor MA,KelleherD. Tolerance of the liver to the effects of yttrum-90 radiation[J].International Journal of Radiation Oncology,Biology,Physics,1990,(03):619-623.
[6]	YU Jun-feng,YIN Duan-zhi,MIN Xiao-feng. (¹⁸⁸Re) Rhenium sulfide suspension:apotential radiopharmaceutical for treatment following intratumor injection[J].Nuclear Medicine and Biology,1999,(26):573-579.
[7]	Yang W,Barth RF,Adams DM. Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors[J].Cancer Research,1997,(19):4333-4339.
[8]	Karim B,Nakhgevany,MobiniJ. Nonabsorbabl radioactive material in the treatment of carcinomas by local injection[J].Cancer,1988,(03):931-940.
[9]	WT Leung. Clinical evaluation of the parition model for estimating radiation doses from yttrum-90 glass micro spheres in the treatment of hepatic cancer[J].European Journal of Nuclear Medicine,1997,(03):293-298.
[10]	Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies[J].Journal of Nuclear Medicine,1997,(07):1169-1170.
[11]	Agamemnon A,Epeneto S,Deborah Snook. Limitation of radiolabled monoclonal antibodies for localization of human neoplasmas[J].Cancer Research,1986.3183-3191.
[12]	Rivo P,Agostino A,Vittorio T. Intralesional radioimmunotherapy of malignant gliomas[J].Cancer,1994,(zk):1076-1081.
[13]	Hopkins K,Chandler C,Bullimore J. A pilot study of the treatment of patients with recurrent malignant gliomas with intratumoral yttrum-90 radioimmunoconjugates[J].Radiotherapy and Oncology,1995,(02):121-131.
[14]	Denittis AS,Stambaugh MD,Lang P. Complete remission of nonresectable pancreatic cancer after infisional colloidal phosphorus-32 brachytherapy,external beam radiation therapy,and 5-fluorouracil:preliminary report[J].American Journal of Clinical Oncology,1999,(04):355-360.

[1]	朱爱芝 . 多巴胺D₃受体配体研究现状. 国际放射医学核医学杂志, 2002, 26(2): 53-56.
[2]	袁杰 , 刘兴党 , 韩梅 . SPECT、PET神经受体和转运体显像技术在海洛因成瘾研究中的应用. 国际放射医学核医学杂志, 2013, 37(1): 30-33, 41. doi: 10.3760/cma.j.issn.1673-4114.2013.01.009
[3]	杨敏 . ¹²³I-epidepride:多巴胺D₂受体显像剂. 国际放射医学核医学杂志, 2000, 24(2): 67-70.
[4]	杨敏 . ¹⁸F-fallypride:一种多巴胺D2受体PET显像剂. 国际放射医学核医学杂志, 2003, 27(6): 259-262.
[5]	曹国祥 , 谭天秩 . 多巴胺受体及其SPECT显像研究. 国际放射医学核医学杂志, 1998, 22(2): 69-72.
[6]	任均田 . 以MAG3为配体的¹⁸⁶Re标记单克隆抗体:配体数目与生物学分布的关系. 国际放射医学核医学杂志, 1997, 21(3): 121-121.
[7]	袁洪卫 , 林汉 . G蛋白偶联受体及其配体的结构与功能分析. 国际放射医学核医学杂志, 1996, 20(3): 112-115.
[8]	曹国祥 , 谭天秩 . 多巴胺受体显像剂的研究概况. 国际放射医学核医学杂志, 1999, 23(2): 65-67.
[9]	李云春 , 管昌田 . 毒蕈碱受体SPECT显像的新配体IQNP的合成和生物学分布. 国际放射医学核医学杂志, 1994, 18(2): 91-92.
[10]	王荣福 . 多巴胺能神经递质及受体显像的临床研究和应用进展. 国际放射医学核医学杂志, 2000, 24(2): 59-62.